healthcare

MEDIROM Healthcare Technologies Inc. (MRM) has regained compliance with Nasdaq’s minimum bid price requirement. After receiving a notice of non-compliance on February 27, 2025, MEDIROM’s ADSs closed above $1.00 for ten consecutive business days, satisfying the exchange’s mandate. This positive development, announced June 5, 2025, signifies the company’s commitment to regulations and follows a period of uncertainty. MEDIROM operates over 300 wellness salons in Japan and offers health-tech solutions.

The article explores the potential and pitfalls of AI in healthcare. While AI doctors promise improved precision, studies reveal they can amplify existing biases in treatment based on factors like income, gender, or race. Concerns about data quality and inherent biases within healthcare systems necessitate adjustments. The solution involves a shift from a disease-centered approach to a focus on the overall patient, alongside ongoing medical progress and the use of data.

Ant Group’s “AI Health Guardian” has passed CAICT’s trustworthiness evaluation for large-scale medical health models, confirming its reliability. Launched in September 2024, the AI-powered service provides doctor recommendations, health assessments, and more. It leverages a medical-focused language model and has already served 40 million users, demonstrating successful integration and collaboration within healthcare.

Nutex Health Inc. (NUTX) announced its 2025 annual shareholder meeting details and availability of proxy materials. The virtual meeting is scheduled for July 14, 2025, and accessible online. Shareholders can access documents via several methods, including www.ProxyVote.com. Nutex operates micro-hospitals and physician networks, aiming to streamline healthcare. The announcement includes forward-looking statements and encourages shareholder participation.

Bill Gates plans to direct the majority of his foundation’s $200 billion philanthropic initiative towards Africa over the next two decades. This aims to improve healthcare, education, and economic growth, fighting poverty and disease. The funds will support existing programs and launch new initiatives, focusing on eradicating diseases and preventing avoidable deaths. Gates also criticized Elon Musk for reducing international aid budgets.

Progyny, a leader in women’s health and family-building benefits, appointed Elizabeth Bierbower to its Board of Directors. This strategic move aims to leverage Bierbower’s three decades of healthcare experience, including leadership roles at Friday Health Plans and Humana, to support Progyny’s growth. The appointment reflects Progyny’s expansion plans and commitment to providing comprehensive solutions, focusing on improved outcomes and reduced costs.

Johnson & Johnson will release its second-quarter results on Wednesday, July 16th, at 8:30 AM Eastern Time. Led by CEO Joaquin Duato, the call will cover the company’s performance and strategy. Investors can access the webcast and presentation materials on J&J’s website, as well as dial-in for the call. Replays will also be available. The press release will be available that morning. The tentative date for the Q3 earnings call is October 14, 2025.